Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 2

2(33.3%)

Phase 1

2(33.3%)

Phase 3

1(16.7%)

N/A

1(16.7%)

6Total

Phase 2(2)

Phase 1(2)

Phase 3(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT04796350Not ApplicableRecruiting

RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures

Role: collaborator

NCT03487549Phase 2Completed

Cantharidin and Occlusion in Verruca Epithelium

Role: collaborator

NCT03981822Phase 2Completed

A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts

Role: collaborator

NCT04607005Phase 3Completed

Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)

Role: collaborator

NCT05713773Phase 1Completed

Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects

Role: collaborator

NCT03333447Completed

Retrospective and Prospective Observational Study of MRI Changes in Bone and Visceral Lesions of Patients With Type 1 Gaucher Disease Treated With VPRIV® (Velaglucerase Alfa)

Role: collaborator

NCT01692353Completed

Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers

Role: collaborator

NCT02119091Phase 1Unknown

Race Difference Moxifloxacin-induced QT Prolongation Between Healthy Chinese and Caucasian Volunteers

Role: collaborator

All 8 trials loaded